Literature DB >> 26223347

Relationship between blood pressure variability and renal activity of the renin-angiotensin system.

N Ozkayar1, F Dede1, F Akyel1, T Yildirim2, I Ateş1, T Turhan3, B Altun2.   

Abstract

Local renin-angiotensin system (RAS) activity in the kidneys is a pathogenetic factor in patients with primary hypertension. This study aimed to determine the relationship between local kidney RAS activity and blood pressure variability, as the literature currently lacks any such study. The study included 73 consecutive primary hypertensive patients. All patients underwent 24-h ambulatory blood pressure monitoring to determine the average real variability (ARV) index, as an indicator of blood pressure variability. Local RAS activity was determined using the urine angiotensinogen/creatinine (UAGT/UCre) ratio. The high UAGT/UCre ratio group had significantly higher mean 24-h systolic ARV than the low UAGT/UCre ratio group (13.2±3.4 vs 11.0±2.6, P=0.003). Similarly, the high UAGT/UCre ratio group had significantly higher mean 24-h diastolic ARV than the low UAGT/UCre ratio group (10.8±3.2 vs 8.7±2.2, P=0.001). Multivariate regression analysis showed that Log(UAGT/UCre) was an independent predictor of both 24-h diastolic ARV and 24-h systolic ARV. Local RAS activity in the kidneys might have a role in blood pressure variability. On the basis of these findings, we think that additional prospective studies are needed to more fully discern the effect of local RAS activity on blood pressure variability.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26223347     DOI: 10.1038/jhh.2015.71

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  38 in total

1.  Blood pressure and renin-angiotensin system resetting in transgenic rats with elevated plasma Val5-angiotensinogen.

Authors:  Jürgen Bohlender; Michael Bader; Joël Ménard; Jürg Nussberger
Journal:  J Hypertens       Date:  2012-08       Impact factor: 4.844

2.  In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system.

Authors:  J R Ingelfinger; W M Zuo; E A Fon; K E Ellison; V J Dzau
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Arterial stiffness and 24 h ambulatory blood pressure monitoring in young healthy volunteers: the early vascular ageing Aristotle University Thessaloniki Study (EVA-ARIS Study).

Authors:  Vasilios Kotsis; Stella Stabouli; Ioannis Karafillis; Sofia Papakatsika; Zoe Rizos; Spiros Miyakis; Sofia Goulopoulou; Gianfranco Parati; Peter Nilsson
Journal:  Atherosclerosis       Date:  2011-07-30       Impact factor: 5.162

4.  The brain renin-angiotensin system modulates angiotensin II-induced hypertension and cardiac hypertrophy.

Authors:  O Baltatu; J A Silva; D Ganten; M Bader
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

5.  Urinary angiotensinogen excretion is associated with blood pressure independent of the circulating renin-angiotensin system in a group of african ancestry.

Authors:  Frederic S Michel; Gavin R Norton; Muzi J Maseko; Olebogeng H I Majane; Pinhas Sareli; Angela J Woodiwiss
Journal:  Hypertension       Date:  2014-04-28       Impact factor: 10.190

6.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

7.  Neural and humoral mechanisms involved in blood pressure variability.

Authors:  J Conway; N Boon; C Davies; J V Jones; P Sleight
Journal:  J Hypertens       Date:  1984-04       Impact factor: 4.844

8.  Urinary angiotensinogen level is correlated with proteinuria in renal transplant recipients.

Authors:  S Erdogmus; S Sengul; S Kocak; I Kurultak; Z K Celebi; S Kutlay; K Keven; B Erbay; S Erturk
Journal:  Transplant Proc       Date:  2013-04       Impact factor: 1.066

Review 9.  A tool for reliable self-home blood pressure monitoring designed according to the European Society of Hypertension recommendations: the Microlife WatchBP Home monitor.

Authors:  George S Stergiou; Bernd Jaenecke; Periklis P Giovas; Arron Chang; Yen Chung-Yueh; Ty-Minh Tan
Journal:  Blood Press Monit       Date:  2007-04       Impact factor: 1.444

10.  [Angiotensin II contents in plasma, and cardiac and renal tissues of sinoaortic denervated rats].

Authors:  Zheng-Zheng Shan; Sheng-Ming Dai; Feng Fang; Ding-Feng Su
Journal:  Sheng Li Xue Bao       Date:  2003-02-25
View more
  5 in total

1.  Positive association between KCNJ5 rs2604204 (A/C) polymorphism and plasma aldosterone levels, but also plasma renin and angiotensin I and II levels, in newly diagnosed hypertensive Chinese: a case-control study.

Authors:  H Wang; C Weng; H Chen
Journal:  J Hum Hypertens       Date:  2017-01-19       Impact factor: 3.012

2.  Ambulatory Blood Pressure in Chronic Kidney Disease: Ready for Prime Time?

Authors:  Manuel T Velasquez; Srinivasan Beddhu; Ehsan Nobakht; Mahboob Rahman; Dominic S Raj
Journal:  Kidney Int Rep       Date:  2016-06-04

3.  Twenty-four-hour systolic blood pressure variability and renal function decline in elderly male hypertensive patients with well-controlled blood pressure.

Authors:  Xi Wang; Fan Wang; Minzhi Chen; Xiaona Wang; Jin Zheng; Aimei Qin
Journal:  Clin Interv Aging       Date:  2018-04-04       Impact factor: 4.458

4.  Short-Term Systolic Blood Pressure Variability and Kidney Disease Progression in Patients With Chronic Kidney Disease: Results From C-STRIDE.

Authors:  Qin Wang; Yu Wang; Jinwei Wang; Luxia Zhang; Ming-Hui Zhao
Journal:  J Am Heart Assoc       Date:  2020-06-06       Impact factor: 5.501

5.  Relationship between saline infusion and blood pressure variability in non-critically patients with hypertension: A retrospective study.

Authors:  Jianhua Wu; Junjie Nie; Yue Wang; Yingpei Zhang; Dongfang Wu
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.